ADENOCARCINOMA OF LUNG
Clinical trials for ADENOCARCINOMA OF LUNG explained in plain language.
Never miss a new study
Get alerted when new ADENOCARCINOMA OF LUNG trials appear
Sign up with your email to follow new studies for ADENOCARCINOMA OF LUNG, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Electric fields could prime immune system against lung cancer
Disease control OngoingThis early-phase trial is testing whether a device that delivers electric fields (TTFields) to lung tumors is safe and practical when used for 3 weeks before surgery. The study includes 12 people with early-stage lung adenocarcinoma. Researchers also want to see if this treatment…
Matched conditions: ADENOCARCINOMA OF LUNG
Phase: PHASE1 • Sponsor: Memorial Sloan Kettering Cancer Center • Aim: Disease control
Last updated Jun 27, 2026 12:39 UTC
-
New drug shows promise for Hard-to-Treat lung cancer
Disease control OngoingThis early-phase trial tests a drug called HER3-DXd in people with advanced non-small cell lung cancer that has spread or cannot be removed by surgery. The study includes patients with specific genetic changes (EGFR or KRAS mutations) whose cancer worsened after other treatments.…
Matched conditions: ADENOCARCINOMA OF LUNG
Phase: PHASE1 • Sponsor: Daiichi Sankyo • Aim: Disease control
Last updated Jun 27, 2026 09:10 UTC
-
CRISPR Gene-Edited immune cells aim to fight lung cancer – but trial never started
Disease control TerminatedThis early-phase trial planned to test a new approach for people with metastatic non-small cell lung cancer. Doctors would remove immune cells from the tumor, edit them with CRISPR to remove a gene called CISH, and then infuse them back to help fight the cancer. However, the tria…
Matched conditions: ADENOCARCINOMA OF LUNG
Phase: PHASE1, PHASE2 • Sponsor: Intima Bioscience, Inc. • Aim: Disease control
Last updated Jun 27, 2026 09:08 UTC
-
New drug combo shows promise for Hard-to-Treat cancers
Disease control OngoingThis study tests a new drug called PF-07220060 in people with advanced solid tumors, including breast, prostate, lung, and liposarcoma cancers. The drug is given alone or with hormone therapies to see if it is safe and works. About 362 participants will take part to find the best…
Matched conditions: ADENOCARCINOMA OF LUNG
Phase: PHASE2 • Sponsor: Pfizer • Aim: Disease control
Last updated Jun 27, 2026 07:53 UTC